A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma, Diana Wing Lee, Bihua Li et al. · Cell · 2010
Cited by 2,750 works. doi:10.1016/j.cell.2010.02.027 Open-access PDF
Authors
- Sreenath V. Sharma
- Diana Wing Lee
- Bihua Li
- Margaret P. Quinlan
- Fumiyuki Takahashi
- Shyamala Maheswaran
- Ultan McDermott
- Nancy G. Azizian
- Lee Zou
- Michael Andrew Fischbach
- Kwok‐Kin Wong
- Ben S. Wittner
- Sridhar Ramaswamy
- Marie Classon
- Jeff Settleman
References
- Cancerous stem cells can arise from pediatric brain tumors
- Bacterial Persistence as a Phenotypic Switch
- Anticancer activities of histone deacetylase inhibitors
- Insulin and insulin-like growth factor signalling in neoplasia
- The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
- Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
- Persister cells, dormancy and infectious disease
- Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product
- Global histone modification patterns predict risk of prostate cancer recurrence
- Transcriptome-wide noise controls lineage choice in mammalian progenitor cells